Loading…
Based on limited metadata, the FDA issued a warning letter to Biotek, Inc. on March 13, 2018, regarding an unspecified product category classified as "Other." Without access to the complete warning letter text or detailed subject line information, the specific nature of the regulatory violations cannot be determined from the available metadata alone. The issuing office is also not identified in the metadata provided. To understand the full scope and details of the violations, the complete FDA warning letter document would need to be reviewed.